Clinical trial
Development of Eye-movement Based Biomarkers in Alzheimer's Disease
NCT05176704 is registered in ClinicalTrials.gov with McGill University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Development of Eye-movement Based Biomarkers in Alzheimer's Disease
- Lead sponsor
- McGill University
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- May 19, 2026
- Completion date
- November 30, 2027
- Enrollment
- 250 (estimated)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.
alzheimer's disease, healthy controls